Shopping Cart
- Remove All
Your shopping cart is currently empty
Kynurenic acid
Catalog No. T65135Cas No. 492-27-3
Alias Quinurenic acid, Fibrostop 2
Kynurenic acid (Quinurenic acid) is an endogenous tryptophan active metabolite, a triple antagonist of NMDA, glutamate, α7 nicotinic acetylcholine receptor, and an agonist of GPR35/CXCR8 with neuroprotective and anticonvulsant properties. It has neuroprotective and anticonvulsant properties and can be used to study neurodegeneration and metabolism-related diseases.
Kynurenic acid
Catalog No. T65135Alias Quinurenic acid, Fibrostop 2Cas No. 492-27-3
Kynurenic acid (Quinurenic acid) is an endogenous tryptophan active metabolite, a triple antagonist of NMDA, glutamate, α7 nicotinic acetylcholine receptor, and an agonist of GPR35/CXCR8 with neuroprotective and anticonvulsant properties. It has neuroprotective and anticonvulsant properties and can be used to study neurodegeneration and metabolism-related diseases.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 50 mg | $31 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "Kynurenic acid"
L-Glutamic acid monosodium salt
MSG, Monosodium glutamate, Glutavene, Glutacyl, Ajinomoto
T6871142-47-2
L-Glutamic acid monosodium salt (MSG) (Monosodium glutamate) is an activator of mGlu1 receptor.
- $33
Size
QTY
Riluzole
RP-54274, PK 26124
T03491744-22-5
Riluzole (RP-54274) is a glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
- $45
Size
QTY
Halothane
Narcotane, Anestan
T0954151-67-7
Halothane (Anestan) is a nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required.
- $45
Size
QTY
Evans blue
Direct Blue 53, C.I. 23860
T0313314-13-6
Evans blue (C.I. 23860) is an azo dye, inhibits L-glutamate uptake via the membrane-bound excitatory amino acid transporter (EAAT).
- $41
Size
QTY
O-Phospho-L-serine
Phosphoserine, L-SOP, L-Serine O-phosphate, Dexfosfoserine
T1324407-41-0
O-Phospho-L-serine (Phosphoserine) is the phosphoric acid ester of serine.
- $33
Size
QTY
Benzyl nicotinate
Rubriment, Pycaril
T771394-44-0
Benzyl nicotinate (Pycaril) is a agonist of GPR109A receptor and GPR109B receptor
- $29
Size
QTY
Mephenesin
Mephedan, Memphenesin, Decontractyl, Cresoxydiol
T001559-47-2
Mephenesin (Cresoxydiol) is a centrally acting muscle relaxant with a short duration of action.
- $33
Size
QTY
Monomethyl fumarate
T120952756-87-8
Monomethyl fumarate is a potent agonist of GPR109A .
- $42
Size
QTY
L-Glutamine
Cited
L-Glutamic acid 5-amide
T0326L56-85-9
L-Glutamine (L-Glutamic acid 5-amide), a non-essential amino acid, is synthesized from glutamic acid and ammonia.
- $29
Size
QTY
CitedDirect Blue 1
Pontamine sky blue, Chicago Sky Blue 6B
T21942610-05-1
Direct Blue 1 (Pontamine sky blue), a counterstain for background autofluorescence in immunofluorescence histochemistry, structurally resembles glutamate and operates as a potent, competitive VGLUT inhibitor, not impacting plasma membrane transporters. This compound stands out as the inaugural small molecule PrP ligand to inhibit Aβ binding.
- $42
Size
QTY
Procaine hydrochloride
Procaine HCl, Novocaine HCl
T080251-05-8
Procaine hydrochloride (Novocaine HCl) is the hydrochloride salt form of procaine, a benzoic acid derivative with local anesthetic and antiarrhythmic properties. Procaine binds to and inhibits voltage-gated sodiumchannels, thereby inhibiting the ionic flux required for the initiation and conduction of impulses. In addition, this agent increases electrical excitation threshold, reduces rate of rise of action potential and slows nerve impulse propagation thereby causing loss of sensation.
- $31
Size
QTY
Decanoic Acid
Decoic acid, Caprynic acid, CAPRIC ACID
T3379334-48-5
Decanoic Acid (Caprynic acid) acts as a non-competitive AMPA receptor antagonist.
- $42
Size
QTY
Select Batch
Purity:99.69%
Contact us for more batch information
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.Product Introduction
Bioactivity
Chemical Properties
| Description | Kynurenic acid (Quinurenic acid) is an endogenous tryptophan active metabolite, a triple antagonist of NMDA, glutamate, α7 nicotinic acetylcholine receptor, and an agonist of GPR35/CXCR8 with neuroprotective and anticonvulsant properties. It has neuroprotective and anticonvulsant properties and can be used to study neurodegeneration and metabolism-related diseases. |
| Alias | Quinurenic acid, Fibrostop 2 |
| Molecular Weight | 189.17 |
| Formula | C10H7NO3 |
| Cas No. | 492-27-3 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
| Solubility Information | H2O: <0.1 mg/mL (insoluble) DMSO: 12.5 mg/mL (66.07 mM), Sonication is recommended.  | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Kynurenic acid | purchase Kynurenic acid | Kynurenic acid cost | order Kynurenic acid | Kynurenic acid chemical structure | Kynurenic acid formula | Kynurenic acid molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.